SCHEMBL6779305

SCHEMBL6779305

COc1ccccc1N(Cc1ccc2ccccc2c1)C(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 2/20 0.53
ALOX5 P09917 2/20 0.53
TP53 P04637 2/20 0.48
THRB P10828 1/20 0.48
HTT P42858 1/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
LMNA P02545 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PDK2 Q15119 1/20 0.44
PDK4 Q16654 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PDK1 Q15118 1/20 0.44
DRD2 P14416 1/20 0.44
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778747 0.86 NPC1 (0.55) MEN1KMT2AALDH1A1KDM4EMAPK1
SCHEMBL6784816 0.85 PTGES (0.60) PTGESALOX5TP53HTTALDH1A1
SCHEMBL6778659 0.84 ALDH1A1 (0.49) TP53THRBHTTMEN1KMT2A
SCHEMBL6781113 0.79 PTGES (0.60) PTGESALOX5TP53MEN1KMT2A
SCHEMBL12368118 0.77 TSHR (0.50) MEN1KMT2AALDH1A1KDM4EMAPK1
SCHEMBL6775052 0.74 HTT (0.49) TP53THRBHTTMEN1KMT2A
SCHEMBL29009654 0.72 TP53 (0.49) PTGESALOX5TP53HTTMEN1
SCHEMBL18116227 0.72 TSPO (0.61)
SCHEMBL30958894 0.72 POLB (0.62) PTGESALOX5TP53THRBMEN1
SCHEMBL9240324 0.71 ABCB1 (0.46) HTTMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT PTGES 902/4885ALOX5 1156/4885TP53 4800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.